Spontaneous bacterial peritonitis in non-cirrhotic portal hypertension secondary to primary myelofibrosis: A rare case report. [PDF]
Pradana FR, Nuramalia LS, Maimunah U.
europepmc +1 more source
Content validation of the Myelofibrosis Symptom Assessment Form version 4.0 (MFSAF v4.0) in Janus kinase inhibitor-experienced patients with myelofibrosis. [PDF]
Cutts K +4 more
europepmc +1 more source
Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges. [PDF]
Maltese T +6 more
europepmc +1 more source
Isolated Subcarinal Lymph Node Recurrence 24 Years After Treatment for Primary Tracheal Adenoid Cystic Carcinoma. [PDF]
Suzuki Y +8 more
europepmc +1 more source
Cutaneous Extramedullary Hematopoiesis in Primary Myelofibrosis: A Case Report With Rapidly Fatal Outcome. [PDF]
El Bouhmadi A +4 more
europepmc +1 more source
Prospects of Chimeric Antigen Receptor T-Cell Therapy in Myelofibrosis: From Immunopathogenesis to Therapeutic Strategies. [PDF]
Kong L +7 more
europepmc +1 more source
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis. [PDF]
Polepally AR +7 more
europepmc +1 more source
Assessment of flonoltinib maleate versus ruxolitinib phosphate in intermediate- to high-risk myelofibrosis (FMF-02): study protocol for a multicenter, randomized, open-label phase IIB trial. [PDF]
Yang L +5 more
europepmc +1 more source
Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]
Freire C +8 more
europepmc +1 more source
A breakthrough invasive <i>Aspergillus granulosus</i> infection following azole antifungal therapy in a patient with primary myelofibrosis: case report. [PDF]
Jaroensawang W +3 more
europepmc +1 more source

